Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl] amino} pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors

被引:50
作者
Nagashima, Shinya
Yokota, Masaki
Nakai, Ei-ichi
Kuromitsu, Sadao
Ohga, Keiko
Takeuchi, Makoto
Tsukamoto, Shin-ichi
Ohta, Mitsuaki
机构
[1] Astellas Pharma Inc, Inst Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan
[2] Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
关键词
signal transducers and activators of transcription 6; allergic disease; interleukin-4; Th2; differentiation;
D O I
10.1016/j.bmc.2006.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The STAT6 (signal transducers and activators of transcription 6) protein is activated by interleukin (IL)-4 and IL-13, and plays an important role in T-helper cell 2 (Th2) differentiation. STAT6 might therefore be an excellent therapeutic target for various allergic conditions, including asthma and atopic diseases. We synthesized a series of 2-{[2-(4-hydroxyphenyl)ethyl]amino}pyrimidine-5-carboxamide derivatives and evaluated their STAT6 inhibitory activities. Among these compounds, 4-(benzylamino)-2-{[2-(3-chloro-4-hydroxyphenyl)ethyl]amino}pyrimidine-5-carboxamide (2t, AS1517499) showed potent STAT6 inhibition with an IC50 value of 21 nM, and also inhibited IL-4-induced Th2 differentiation of mouse spleen T cells with an IC50 value of 2.3 nM and without influencing T-helper cell 1 (Th1) differentiation induced by IL-12. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1044 / 1055
页数:12
相关论文
共 13 条
  • [1] Manipulation of the Th1/Th2 cell balance: An approach to treat human autoimmune diseases?
    Adorini, L
    Guery, JC
    Trembleau, S
    [J]. AUTOIMMUNITY, 1996, 23 (01) : 53 - 68
  • [2] Foster PS, 1999, CLIN EXP ALLERGY, V29, P12
  • [3] A RESTRICTED CYTOPLASMIC REGION OF IL-2 RECEPTOR-BETA-CHAIN IS ESSENTIAL FOR GROWTH SIGNAL TRANSDUCTION BUT NOT FOR LIGAND-BINDING AND INTERNALIZATION
    HATAKEYAMA, M
    MORI, H
    DOI, T
    TANIGUCHI, T
    [J]. CELL, 1989, 59 (05) : 837 - 845
  • [4] Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives
    Hisamichi, H
    Naito, R
    Toyoshima, A
    Kawano, N
    Ichikawa, A
    Orita, A
    Orita, M
    Hamada, N
    Takeuchi, M
    Ohta, M
    Tsukamoto, SI
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (16) : 4936 - 4951
  • [5] Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells
    Kaplan, MH
    Schindler, U
    Smiley, ST
    Grusby, MJ
    [J]. IMMUNITY, 1996, 4 (03) : 313 - 319
  • [6] EVIDENCE FOR A CRITICAL ROLE FOR THE CYTOPLASMIC REGION OF THE INTERLEUKIN-2 (IL-2) RECEPTOR-GAMMA CHAIN IN IL-2, IL-4, AND IL-7 SIGNALING
    KAWAHARA, A
    MINAMI, Y
    TANIGUCHI, T
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) : 5433 - 5440
  • [7] 3-(13-hydroxytridecyl)-1-[13-(3-pyridyl)tridecyl] pyridinium chloride (YM-53792), a novel inhibitor of NF-AT activation
    Kuromitsu, S
    Fukunaga, M
    Lennard, AC
    Masuho, Y
    Nakada, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (09) : 999 - 1005
  • [8] The expanding universe of T-cell subsets: Th1, Th2 and more
    Mosmann, TR
    Sad, S
    [J]. IMMUNOLOGY TODAY, 1996, 17 (03): : 138 - 146
  • [9] New therapeutic strategies in allergic diseases
    Romagnani, S
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 849 - 865
  • [10] IDENTIFICATION OF A CONSERVED LIPOPOLYSACCHARIDE-PLUS-INTERLEUKIN-4-RESPONSIVE ELEMENT LOCATED AT THE PROMOTER OF GERM LINE EPSILON-TRANSCRIPTS
    ROTHMAN, P
    LI, SC
    GORHAM, B
    GLIMCHER, L
    ALT, F
    BOOTHBY, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (11) : 5551 - 5561